Trial intelligence / Profile preview

Warfarin and oseltamivir interaction in volunteers stabilized on warfarin therapy

2007-005037-11Phase 4Completed

Sponsor
Roche
Start
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of oseltamivir and warfarin in influenza and venous thromboembolism (VTE) (2 arms), sponsored by Roche. Primary endpoint: Safety and tolerability. Started Nov 2007; status: completed.

02

Drugs

oseltamivirwarfarin
03

Conditions

influenzavenous thromboembolism (VTE)

Beyond the preview

Go deeper on 2007-005037-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005037-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call